Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BPMC

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BPMC
DateTimeSourceHeadlineSymbolCompany
01/17/20253:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
01/15/20255:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
01/15/20255:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
01/14/20253:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
01/13/202510:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPMCBlueprint Medicines Corporation
01/12/20253:00PMPR Newswire (US)Blueprint Medicines Provides 2025 Outlook and Highlights Strategy for Continued GrowthNASDAQ:BPMCBlueprint Medicines Corporation
12/20/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
12/20/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
12/19/20244:17PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
12/18/20243:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPMCBlueprint Medicines Corporation
12/18/20247:00AMPR Newswire (US)Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
12/16/20246:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
12/12/20243:52PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
12/07/202411:30AMPR Newswire (US)Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual MeetingNASDAQ:BPMCBlueprint Medicines Corporation
12/03/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
12/02/20245:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
11/29/202412:40PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
11/27/20245:51PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
11/22/20243:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
11/21/20243:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
11/20/20243:30PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
11/12/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
11/12/202412:44PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:BPMCBlueprint Medicines Corporation
11/07/20244:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
10/30/20243:27PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPMCBlueprint Medicines Corporation
10/30/20246:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPMCBlueprint Medicines Corporation
10/30/20246:00AMPR Newswire (US)Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue GuidanceNASDAQ:BPMCBlueprint Medicines Corporation
10/16/20247:00AMPR Newswire (US)Blueprint Medicines to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024NASDAQ:BPMCBlueprint Medicines Corporation
10/04/20244:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
09/11/20243:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPMCBlueprint Medicines Corporation
 Showing the most relevant articles for your search:NASDAQ:BPMC